{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:31:28Z","timestamp":1772893888822,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.vaccine.2003.08.017","type":"journal-article","created":{"date-parts":[[2003,9,17]],"date-time":"2003-09-17T04:55:50Z","timestamp":1063774550000},"page":"740-746","source":"Crossref","is-referenced-by-count":20,"title":["Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C"],"prefix":"10.1016","volume":"22","author":[{"given":"Rogerio P.","family":"Mazzantini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane N.","family":"Miyaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldely O.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirce","family":"Sakauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00facia T.O.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa\u0131\u0301as","family":"Raw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Gicquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana C.C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.08.017_BIB1","unstructured":"WHO; 2002."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB2","unstructured":"Fennelly GJ, Jacobs Jr WR, Bloom BR. The BCG as a recombinant vaccine vector. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines. 2nd ed. New York: Marcel Dekker Inc; 1997. p. 363\u201385."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/biol.1995.0021","article-title":"BCG as a vector for the construction of multivalent recombinant vaccines","volume":"23","author":"Gicquel","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB4","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/S0264-410X(01)00155-4","article-title":"Recombinant BCG vaccines","volume":"19","author":"Ohara","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/13500872-141-7-1585","article-title":"Recombinant BCG expressing the Leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB\/c mice","volume":"141","author":"Abdelhak","year":"1995","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB6","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","article-title":"Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Gu\u00e9rin vaccines expressing pneumococcal surface protein A","volume":"180","author":"Langermann","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB8","unstructured":"Cassat DR, de la Cruz VF, Burlein JE, Koenig S, Stover CK. Protection of mice against tetanus challenge using an experimental tetanus vaccine based on recombinant BCG. In: Gingsberg HS, Brown F, Channock RM, Lerner RA, editors. New York, Plainview: Vaccines; 1993. p. 385\u20139."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.188.5.845","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gama and parasite-specific antibodies","volume":"188","author":"Matsumoto","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB10","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/IAI.67.10.5100-5105.1999","article-title":"Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein","volume":"67","author":"Abomoelak","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB11","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1128\/jb.176.21.6749-6753.1994","article-title":"Escherichia coli\u2013Mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series","volume":"176","author":"Gicquel","year":"1994","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB12","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0264-410X(00)00070-0","article-title":"Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE","volume":"18","author":"Himmelrich","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/jb.177.1.59-65.1995","article-title":"Identification of Mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusions","volume":"177","author":"Lim","year":"1995","journal-title":"J. Bacteriol"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.2683073","article-title":"Mutants of pertussis toxin suitable for vaccine development","volume":"246","author":"Pizza","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB15","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM 45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB16","first-page":"1043","article-title":"Expression of tetanus toxin fragment C in E. coli: its purification and potential use as vaccine","volume":"7","author":"Makoff","year":"1989","journal-title":"Biotechnology"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB17","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/IAI.69.2.869-874.2001","article-title":"Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM197, a mutant diphtheria toxin","volume":"69","author":"Miyaji","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB19","unstructured":"Hemert PF. Vaccine production as a unit process. In: Hockenhull DJD, editor. Progress in industrial microbiology. London: Churchill Livingston; 1974. p. 227\u201333."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-1119(91)90587-2","article-title":"Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein","volume":"109","author":"Winter","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2958.1994.tb01037.x","article-title":"Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer","volume":"12","author":"Timm","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB22","first-page":"28","article-title":"Alternative method to remove antibacterial antibodies from antisera used for screening of expression libraries","volume":"19","author":"Gruber","year":"1995","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant Bacille Calmette-Gu\u00e9rin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB24","unstructured":"Picard F. Contribution \u00e0 l\u2019\u00e9tude du contr\u00f4le d\u00e1ctivit\u00e9 des anatoxines t\u00e9taniques purifi\u00e9es simples et adsorb\u00e9es. Th\u00e9se; 1974."},{"key":"10.1016\/j.vaccine.2003.08.017_BIB25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/biol.1994.1009","article-title":"Suitability of the Vero cell method for titration of diphtheria antitoxin in the United States potency test for diphtheria toxoid","volume":"22","author":"Gupta","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB26","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/IAI.64.10.4172-4181.1996","article-title":"Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908","volume":"64","author":"Barry","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0264-410X(01)00343-7","article-title":"Adhoc working group on acellular pertussis vaccines, World Health Organization, Geneva, 27\u201328, 2000","volume":"20","author":"Corbel","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.08.017_BIB28","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1128\/IAI.68.5.2503-2512.2000","article-title":"Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase","volume":"68","author":"Lee","year":"2000","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T16:57:12Z","timestamp":1585155432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":28,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0264410X03006091"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.08.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}